Amedisys
AMED
AMED was delisted on the 14th of August, 2025.
319 hedge funds and large institutions have $3.2B invested in Amedisys in 2025 Q2 according to their latest regulatory filings, with 64 funds opening new positions, 131 increasing their positions, 87 reducing their positions, and 46 closing their positions.
51% more repeat investments, than reductions
Existing positions increased: 131 | Existing positions reduced: 87
39% more first-time investments, than exits
New positions opened: 64 | Existing positions closed: 46
6% more capital invested
Capital invested by funds: $3.02B → $3.2B (+$180M)
5% more funds holding
Funds holding: 304 → 319 (+15)
0.24% less ownership
Funds ownership: 99.35% → 99.1% (-0.24%)
45% less funds holding in top 10
Funds holding in top 10: 11 → 6 (-5)
97% less call options, than puts
Call options by funds: $8.89M | Put options by funds: $334M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$64.6M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
+$41M |
| 3 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$35M |
| 4 |
Renaissance Technologies
New York
|
+$31.1M |
| 5 |
Neuberger Berman Group
New York
|
+$25.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DKCM
Davidson Kempner Capital Management
New York
|
-$62.7M |
| 2 |
CAM
Cresset Asset Management
Chicago,
Illinois
|
-$41.8M |
| 3 |
TCA
Taconic Capital Advisors
New York
|
-$38.2M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$32.8M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$32.5M |
AMED Hedge Fund Activity: Q2 2025 in Review
319 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Amedisys (AMED) for Q2 2025, worth a combined $3.2B — up 6% from $3.02B a quarter earlier.
Buyers outnumbered sellers: 64 funds opened new AMED positions and 46 closed out — a net gain of 18 holders — while 131 added to existing stakes and 87 trimmed.
The largest buyer was Weiss Asset Management, adding an estimated $64.6M. The largest seller was Davidson Kempner Capital Management, cutting an estimated $62.7M.
- 319 institutional investors held Amedisys (AMED) as of Q2 2025, up from 304 in Q1 2025.
- Funds reported $3.2B of Amedisys stock for Q2 2025, up 6% quarter-over-quarter.
- 64 funds opened new Amedisys positions in Q2 2025 and 46 closed out, a net change of +18 holders.
- The largest Amedisys buyer in Q2 2025 was Weiss Asset Management, an estimated $64.6M added.
- The largest Amedisys seller in Q2 2025 was Davidson Kempner Capital Management, an estimated $62.7M sold.
Based on aggregated 13F filings for Q2 2025.